Navigation Links
Blood Type O Associated With Less Risk for Heart Attack
Date:1/15/2011

By Steven Reinberg
HealthDay Reporter

FRIDAY, Jan. 14 (HealthDay News) -- Researchers have simultaneously discovered a gene that seems to raise the risk of cardiovascular disease, while also noting that having the blood type O might guard against heart attack once arteries become clogged.

"Certain genes predispose to heart artery plaque build-up, whereas different genes lead to heart attack when you already have plaque build-up," said study author Dr. Muredach P. Reilly, an associate professor of medicine at the Cardiovascular Institute of the University of Pennsylvania.

One of the more heart-protective genes also helps direct people to have type O blood, the team reported.

The study suggests the multifaceted relationship between genetics and cardiovascular health, Reilly said. "Not all genes for heart disease are equal and therefore have to be used differently in new treatments for heart disease and when assessing risk of heart disease," he said.

The report is published in the Jan. 15 online edition of The Lancet.

For the study, Reilly's team compared almost 13,000 people with coronary artery disease against almost 7,400 people who did not have the condition.

And to hone in on specific genes that might play a role in heart attacks, they compared about 5,800 people with coronary artery disease who had had a heart attack with more than 3,600 people who had coronary artery disease but had never had a heart attack.

Using this method, Reilly's group identified a new gene called ADAMTS7, which was associated with an increased risk of coronary artery disease.

And in the analysis specific to heart attack, they also found an association between blood type and the risk for heart attacks.

Specifically, the gene that makes people have blood type O also protects them from heart attacks, the researchers explained.

Blood is classified as ABO, with eight possible types, determined by the antigens they carry. Type O is know as the universal red cell donor.

"Therapies that modify ADAMTS7 and blood typing may be useful for heart disease, but are likely to work in different ways and different people," Reilly said.

"This concept speaks to future advances in personalized medicine and heart disease treatments. In addition, blood groups might be simple, if crude, indicators of heart attack risk or protection," he said.

But one expert cautioned that while blood type O may offer some protection from heart attack in people with coronary artery disease, that doesn't mean that your blood type alone will spare you from cardiovascular trouble.

"Individuals with blood type O should be just as vigilant about preventing heart disease and stroke as those of other blood types," said Dr. Gregg Fonarow, a professor of cardiology at the University of California, Los Angeles.

Dr. Luca A. Lotta, co-author of accompanying editorial from the Angelo Bianchi Bonomi Hemophia and Thrombosis Center, Luigi Villa Foundation, University of Milan, said the findings "increase our knowledge of the DNA sequences that predispose individuals to develop atherosclerosis and myocardial infarction."

However, there is no direct and immediate clinical application for the findings, she added.

"But, they may lead in the future to the identification of previously unrecognized disease mechanisms and, potentially, to the development of new preventive and therapeutic strategies for these common and severe diseases," Lotta said.

Fonarow noted that, "it is well-established that there are genetic components to the risk of developing coronary atherosclerosis and myocardial infarction."

However, studies have not shown that genetic testing improves risk stratification or has clinical value in determining which treatment should be given over standard care, he said.

More information

For more information on genes and heart disease, visit the American Heart Association.

SOURCES: Muredach P. Reilly, MBBCH, associate professor, medicine, Cardiovascular Institute, University of Pennsylvania, Philadelphia; Luca A. Lotta, M.D., Angelo Bianchi Bonomi Hemophia and Thrombosis Center, Luigi Villa Foundation, University of Milan; Gregg Fonarow, M.D., American Heart Association spokesman and professor, cardiology, University of California, Los Angeles; Jan. 15, 2011, The Lancet, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Bioactive compounds in berries can reduce high blood pressure
2. Room light before bedtime may impact sleep quality, blood pressure and diabetes risk
3. International research team reports major findings in prevention and treatment of blood clots
4. UNC researchers inch closer to unlocking potential of synthetic blood
5. Secondhand Smoke Tied to High Blood Pressure in Kids
6. Embryonic stem cells help deliver good genes in a model of inherited blood disorder
7. Immune Disorders May Raise Blood Clot Risk in Hospitalized Patients
8. Engineering team invents lab-on-a-chip for fast, inexpensive blood tests
9. Early Steps Toward an Alzheimers Blood Test
10. A blood test for Alzheimers disease?
11. Routine blood test may identify people with pre-diabetes, cutting later treatment costs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Type O Associated With Less Risk for Heart Attack
(Date:2/17/2017)... ... February 17, 2017 , ... For ... assistance management solution to the exhibit floor for the 2017 HIMSS Conference ... , From Feb. 19–23, 2017, more than 40,000 healthcare industry professionals are expected ...
(Date:2/17/2017)... Seattle, WA (PRWEB) , ... February 17, 2017 ... ... health management organizations, has been named a finalist in the 8th Annual DecisionHealth ... impacting America's healthcare delivery system. Qualis Health’s work is recognized across multiple award ...
(Date:2/17/2017)... ... 2017 , ... Pharmica Consulting attended CHI's 8th Annual SCOPE ... trial planning and management. Pharmica discussed the importance of effective project management, data ... by Pharmica’s booth were able to demo its cloud-based Resource Management Tool, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from ... February 21 - 23 in Beaver Creek, CO. It was announced today by Cindy ... year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs of ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017  Noble Capital Markets announced today that ... (Nasdaq: EPIX ). The report was issued ... , PhD. ESSA Pharmaceuticals is a clinical ... cancer (CRPC). Its lead compound EPI-506, is a small ... of the androgen receptor, thereby has potential to overcome ...
(Date:2/16/2017)... Quest Diagnostics (NYSE: DGX ), ... announced that it has been named one of the ... The annual survey designated Quest Diagnostics as ... Pharmacy and Other Services" industry to attain Most Admired ... attain the designation. This is the second consecutive year ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
Breaking Medicine Technology: